Psoriasis is an autoimmune skin disease that causes scaling, skin redness and irritation. Psoriasis causes red, scaly patches that are generally found on the elbows, fingernails, scalp, palms, knees, face, feet and inside the mouth. Factors that can trigger psoriasis include infections, heavy alcohol consumption, cold weather, certain medications, smoking, stress and injury to the skin such as bug bite, cut and sever sunburn. The signs and symptoms of psoriasis vary from person to person which includes dry, cracked skin that may bleed, red patches of skin covered with silvery scales, small scaling spots, itching, burning, swollen and stiff joints. Psoriasis may be classified into various types such as plaque psoriasis, scalp psoriasis, pustular psoriasis, psoriatic arthritis, guttate psoriasis, nail psoriasis, erythrodermic psoriasis and inverse psoriasis. Various treatments for psoriasis are oral medication, topical medication and biologics injections. Psoriasis can also be treating by phototherapy treatment which includes ultraviolet light therapy, laser treatment, tanning beds, psoralen +UVA and sunlight treatment. Psoriasis can occur in any part of the body and it is associated with other health conditions such as heart disease, diabetes and depression.

Scope of the Report:

This report studies the Systemic Psoriasis Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Systemic Psoriasis Therapeutics market by product type and applications/end industries.

One trend resulting in the strong growth of this market is the advent of biologics with novel MOA and cell-based strategies. This market is expected to witness the launch of biologic agents that target the disease pathway specifically, including IL-17/IL-17R receptor inhibitors. Drugs such as brodalumab, guselkumab, and tildrakizumab are undergoing Phase III clinical trials.

Factors such as the dominance of market by biologics will drive this market's growth prospects for the near future. Biologics account for over 18% of the global pharmaceutical sales, outpacing the sales of branded pharmaceuticals. These drugs will continue to outperform other pharmaceuticals in terms of product sales as there is an increasing need for innovative products as effective treatment options for a range of indications.

The global Systemic Psoriasis Therapeutics market is valued at xx million in 2017 and is expected to reach xx million by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Systemic Psoriasis Therapeutics.

Europe also play important roles in global market, with market size of xx million in 2017 and will be xx million in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

AbbVie

Johnson & Johnson

Celgene

Amgen

Pfizer

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Biologics

Small Molecules

Market Segment by Applications, can be divided into

Mild Psoriasis

Moderate Psoriasis

Severe Psoriasis

Frequently Asked Questions

These dominant industry players use well planned strategies to occupied highest market share in this market. Some of the top players in [Keyword] business includes. [Company list]
As per [Keyword] market analysis, North America is forecasted to occupied major share in the [Keyword] market.
The statistical data of the dominant industry player of [Keyword] market can be acquired from the company profile segment described in the report. This segment come up with analysis of major player’s in the [Keyword] market, also their last five-year revenue, segmental, product offerings, key strategies adopted and geographical revenue produced.
The report come up with a segment of the [Keyword] market based on Type, Region, and Application, Also offer a determined view on the [Keyword] market.
The report offers a nitty-gritty estimation of the market by providing data on various viewpoints that incorporate, restraints, drivers, and opportunities threats. This data can help in making suitable decisions for stakeholders before investing.
The sample report for [Keyword] market can be received after the apply from the website.

Table Of Content

Table of Contents



1 Systemic Psoriasis Therapeutics Market Overview

    1.1 Product Overview and Scope of Systemic Psoriasis Therapeutics

    1.2 Classification of Systemic Psoriasis Therapeutics by Types

        1.2.1 Global Systemic Psoriasis Therapeutics Revenue Comparison by Types (2017-2023)

        1.2.2 Global Systemic Psoriasis Therapeutics Revenue Market Share by Types in 2017

        1.2.3 Biologics

        1.2.4 Small Molecules

    1.3 Global Systemic Psoriasis Therapeutics Market by Application

        1.3.1 Global Systemic Psoriasis Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)

        1.3.2 Mild Psoriasis

        1.3.3 Moderate Psoriasis

        1.3.4 Severe Psoriasis

    1.4 Global Systemic Psoriasis Therapeutics Market by Regions

        1.4.1 Global Systemic Psoriasis Therapeutics Market Size (Million ) Comparison by Regions (2013-2023)

        1.4.1 North America (USA, Canada and Mexico) Systemic Psoriasis Therapeutics Status and Prospect (2013-2023)

        1.4.2 Europe (Germany, France, UK, Russia and Italy) Systemic Psoriasis Therapeutics Status and Prospect (2013-2023)

        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Systemic Psoriasis Therapeutics Status and Prospect (2013-2023)

        1.4.4 South America (Brazil, Argentina, Colombia) Systemic Psoriasis Therapeutics Status and Prospect (2013-2023)

        1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Systemic Psoriasis Therapeutics Status and Prospect (2013-2023)

    1.5 Global Market Size of Systemic Psoriasis Therapeutics (2013-2023)

2 Manufacturers Profiles

    2.1 AbbVie

        2.1.1 Business Overview

        2.1.2 Systemic Psoriasis Therapeutics Type and Applications

            2.1.2.1 Product A

            2.1.2.2 Product B

        2.1.3 AbbVie Systemic Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

    2.2 Johnson & Johnson

        2.2.1 Business Overview

        2.2.2 Systemic Psoriasis Therapeutics Type and Applications

            2.2.2.1 Product A

            2.2.2.2 Product B

        2.2.3 Johnson & Johnson Systemic Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

    2.3 Celgene

        2.3.1 Business Overview

        2.3.2 Systemic Psoriasis Therapeutics Type and Applications

            2.3.2.1 Product A

            2.3.2.2 Product B

        2.3.3 Celgene Systemic Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

    2.4 Amgen

        2.4.1 Business Overview

        2.4.2 Systemic Psoriasis Therapeutics Type and Applications

            2.4.2.1 Product A

            2.4.2.2 Product B

        2.4.3 Amgen Systemic Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

    2.5 Pfizer

        2.5.1 Business Overview

        2.5.2 Systemic Psoriasis Therapeutics Type and Applications

            2.5.2.1 Product A

            2.5.2.2 Product B

        2.5.3 Pfizer Systemic Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 Global Systemic Psoriasis Therapeutics Market Competition, by Players

    3.1 Global Systemic Psoriasis Therapeutics Revenue and Share by Players (2013-2018)

    3.2 Market Concentration Rate

        3.2.1 Top 5 Systemic Psoriasis Therapeutics Players Market Share

        3.2.2 Top 10 Systemic Psoriasis Therapeutics Players Market Share

    3.3 Market Competition Trend

4 Global Systemic Psoriasis Therapeutics Market Size by Regions

    4.1 Global Systemic Psoriasis Therapeutics Revenue and Market Share by Regions

    4.2 North America Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    4.3 Europe Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    4.4 Asia-Pacific Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    4.5 South America Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    4.6 Middle East and Africa Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

5 North America Systemic Psoriasis Therapeutics Revenue by Countries

    5.1 North America Systemic Psoriasis Therapeutics Revenue by Countries (2013-2018)

    5.2 USA Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    5.3 Canada Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    5.4 Mexico Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

6 Europe Systemic Psoriasis Therapeutics Revenue by Countries

    6.1 Europe Systemic Psoriasis Therapeutics Revenue by Countries (2013-2018)

    6.2 Germany Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    6.3 UK Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    6.4 France Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    6.5 Russia Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    6.6 Italy Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Systemic Psoriasis Therapeutics Revenue by Countries

    7.1 Asia-Pacific Systemic Psoriasis Therapeutics Revenue by Countries (2013-2018)

    7.2 China Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    7.3 Japan Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    7.4 Korea Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    7.5 India Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    7.6 Southeast Asia Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

8 South America Systemic Psoriasis Therapeutics Revenue by Countries

    8.1 South America Systemic Psoriasis Therapeutics Revenue by Countries (2013-2018)

    8.2 Brazil Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    8.3 Argentina Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    8.4 Colombia Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Systemic Psoriasis Therapeutics by Countries

    9.1 Middle East and Africa Systemic Psoriasis Therapeutics Revenue by Countries (2013-2018)

    9.2 Saudi Arabia Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    9.3 UAE Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    9.4 Egypt Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    9.5 Nigeria Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

    9.6 South Africa Systemic Psoriasis Therapeutics Revenue and Growth Rate (2013-2018)

10 Global Systemic Psoriasis Therapeutics Market Segment by Type

    10.1 Global Systemic Psoriasis Therapeutics Revenue and Market Share by Type (2013-2018)

    10.2 Global Systemic Psoriasis Therapeutics Market Forecast by Type (2018-2023)

    10.3 Biologics Revenue Growth Rate (2013-2023)

    10.4 Small Molecules Revenue Growth Rate (2013-2023)

11 Global Systemic Psoriasis Therapeutics Market Segment by Application

    11.1 Global Systemic Psoriasis Therapeutics Revenue Market Share by Application (2013-2018)

    11.2 Systemic Psoriasis Therapeutics Market Forecast by Application (2018-2023)

    11.3 Mild Psoriasis Revenue Growth (2013-2018)

    11.4 Moderate Psoriasis Revenue Growth (2013-2018)

    11.5 Severe Psoriasis Revenue Growth (2013-2018)

12 Global Systemic Psoriasis Therapeutics Market Size Forecast (2018-2023)

    12.1 Global Systemic Psoriasis Therapeutics Market Size Forecast (2018-2023)

    12.2 Global Systemic Psoriasis Therapeutics Market Forecast by Regions (2018-2023)

    12.3 North America Systemic Psoriasis Therapeutics Revenue Market Forecast (2018-2023)

    12.4 Europe Systemic Psoriasis Therapeutics Revenue Market Forecast (2018-2023)

    12.5 Asia-Pacific Systemic Psoriasis Therapeutics Revenue Market Forecast (2018-2023)

    12.6 South America Systemic Psoriasis Therapeutics Revenue Market Forecast (2018-2023)

    12.7 Middle East and Africa Systemic Psoriasis Therapeutics Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

    14.1 Methodology

    14.2 Data Source

Inquiry For Buying

Systemic Psoriasis Therapeutics

Please fill out the form. We will contact you within 24 hours:
All fields required...

Request Sample

Systemic Psoriasis Therapeutics

Please fill out the form. We will contact you within 24 hours:
All fields required...

×

Avail Free PDF Sample Report

This website is secure and your personal details are safe. Privacy Policy

Thank you for contacting us.

Thank you for your interest in our research report.

We will be sending you the sample copy of the report shortly. Meanwhile, if you have any specific research requirement then please let us know. We will be glad to assist you in case you have any additional questions, so feel free to get in touch

Thank you

Warm regards,
Sales | Manager - International Business and partner Relations
Direct line: +1 347 535 0815
Market Research Store
E-mail: sales@MarketResearchStore.com | Web: www.MarketResearchStore.com